Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Effects of Relaxation Training and Stimulus Control in Chronic Insomnia Patients

Key facts

Where
Beijing, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT06658171, who can take part

Where in China

  • Xuanwu Hospital, Capital Medical UniversityBeijing, ChinaContact: Hongxing Wang, MD & PhDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Xuanwu Hospital, Beijing
Trial code
NCT06658171
Record updated
9 May 2025
Original description
The study aims to validate the effect of relaxation training and stimulus control on reducing hyperarousal states and improving maladaptive sleep behaviors.Read full original descriptionShow less

Effects of Relaxation Training and Stimulus Control in Chronic Insomnia Patients With Hyperarousal and Maladaptive Sleep Patterns

The study aims to validate the effect of relaxation training and stimulus control on reducing hyperarousal states and improving maladaptive sleep behaviors.

Inclusion: Meet the diagnostic criteria for insomnia disorder according to DSM-5; Pittsburgh Sleep Quality Index (PSQI) total score > 5; Age ≥ 18 years, with at least a middle school education level; Anxiety symptoms meeting HAMA ≥ 14; "Self-developed 8-item questionnaire on maladaptive sleep behaviors" used to assess "maladaptive sleep behaviors."; Voluntarily participate in this study and sign an informed consent form.

Exclusion: Currently undergoing any psychological therapy; Individuals with severe physical illnesses or severe mental disorders, at risk of suicide; Clinically diagnosed or suspected sleep-related breathing disorders, restless leg syndrome, and sleep-wake rhythm disorders, as well as shift workers; Pregnant or lactating women.

ClinicalTrials.gov NCT06658171